U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07669402) titled 'Comparative Evaluation of Letrozole, L-Carnitine, and Combination Therapy on Sperm Quality and ART Outcomes in Idiopathic Oligoasthenoteratozoospermia: A Three-Arm Randomized Trial' on June 20.
Brief Summary: This is a randomized clinical trial evaluating the efficacy of Letrozole, L-Carnitine, and their combination on sperm quality, oxidative stress, and ART outcomes in men with idiopathic oligoasthenoteratozoospermia.
Study Start Date: Dec. 01, 2023
Study Type: INTERVENTIONAL
Condition:
Idiopathic Oligoasthenoteratozoospermia
Male Infertility
Intervention:
DRUG: Letrozole 2.5mg
Letrozole 2.5 mg tablet administered orally on...